Advertisement
The meeting is scheduled from 10 am - 1 pm, and is open to analysts,shareholders, and others in the investment community. Attendees must registerno later than May 21st. For more information, please contact Denise McEvilyat (781) 356-9457 or [email protected].
Advertisement
Other audiences may participate in the meeting via live webcast.Information on the webcast will be posted on the Company's website the daybefore the event.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated toproviding innovative blood management solutions for our customers. Together,our devices and consumables, information technology platforms, and consultingservices deliver a suite of business solutions to help our customers improveclinical outcomes and reduce the cost of healthcare for blood collectors,hospitals, and patients around the world. Our technologies address importantmedical markets: blood and plasma component collection, the surgical suite,and hospital transfusion services. To learn more about Haemonetics, visit ourweb site at http://www.haemonetics.com.The agenda for the meeting includes: -- Fiscal 2009 annual operating plan review -- Fiscal 2009 transformational restructuring -- Blood Management Solutions strategy -- R&D review
SOURCE Haemonetics Corporation
